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INTRODUCTION
Studies have shown that humans make over 30,000 decisions per day in normal lives.[1] Likewise, 
orthodontists make decisions for their patients in their offices everyday. It is worthwhile for 
orthodontists to understand factors involved in the human decision-making process. Ryan 
Hamilton, in his course guidebook, How You Decide: The Science of Human Decision Making, 
summarized the current research on this topic with the 4 R’s of decision-making that matter: 
reference points, reasons, resources, and replacement.[2] e authors will apply these principles in 
the decision-making necessary for the growing Class III patients.
Reference points and Class III treatment decisions
When people make decisions, losses loom larger than that of gains.[2] Gain or loss is determined 
by comparing to a reference point. In the management of Class III treatment, a clinician may 
choose to recommend early treatment. e reference point is a large negative Wits appraisal. 
e gain would be better early function and more balanced facial esthetics.  e loss, if early 
treatment fails, would be a diminished trust in the clinician’s future treatment recommendations. 
However, if the Class III condition that appears worse is due to a anterior functional shift rather 
than a true skeletal problem, the initial reference point or the large negative Wits appraisal is not 
as severe; treatment outcome will be more favorable with nonsurgical treatment.[3]
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Reasons and Class III treatment decisions
“When a choice for which there is no clearly superior option, 
seemingly almost any reason can serve as grounds for the 
choice.”[2] To treat or not to treat the early Class III condition? 
Some clinicians have had bad experiences or failure when 
treating Class  III patients early and therefore allow growth 
to proceed and postpone the treatment to a later date as a 
surgical case. On the other hand, many clinicians treating 
Class  III patients can find reasons to recommend early 
intervention such as in cases that the parents are very 
concerned, as chewing seems difficult, the occlusal problem 
will worsen with time, maxillary growth will respond to 
orthopedic traction when the patient is younger, and the 
patient is unhappy with dentofacial appearance.[4]
Resources and Class III treatment decisions
e fact that people are limited in terms of attention, effort, 
and self-control has two implications: first, our decision-
making is a function of resources we have available to us. 
We have different decision rules and multiple cognitive 
systems that are geared toward either making fast and 
easy, resource-conserving decisions or slow and deliberative, 
resource-consuming decisions. We slip into the easier, 
resource-conserving mode any time we are exhausted or 
distracted.[2] Second, because decisions consume these 
limited resources, people have become strategic in how 
they spend them. Humans have developed sacrificing rules, 
habitual responses, and availability heuristics.”[2]
For the growing Class III patient, then, the clinician should 
make every effort to assess the “resources” and pay attention 
to the plan and potential compliance of the patient and the 
family. Resource assessment takes provider time and requires 
effective patient education. While this can be delegated to an 
experienced treatment coordinator, both patients and parents 
will engage more of their “resources” if the educational 
material is presented by the orthodontist who is the decision-
maker.
Replacement and Class III treatment decisions
is consideration in decision-making relates to the fact that 
when people are presented with difficult tasks, they will often 
replace a difficult task with a perceived easier one.[2]
For example, in Class  III treatment, if a child patient finds 
it difficult to wear a reverse pull headgear to the maxilla for 
10–12 h a day, he/she may decline to cooperate as needed. 
rough the “replacement mechanism,” the child may use his 
or her limited youthful wisdom by persuading the parents 
and the orthodontist to replace the reverse pull headgear 
with a surgical solution even though they do not really know 
what that entails and the associated risks/costs.
Decision-making for early Class III treatment
Class  III malocclusion can be diagnosed as early as primary 
dentition.[5] Young patients presented with a Class  III molar 
relationship, and an anterior crossbite may have a combination 
of skeletal, dentoalveolar, and functional components 
[Figure 1].[6] To complicate the diagnosis further, the skeletal 
component of Class  III malocclusions frequently has 
contributions of maxillary deficiency and mandibular excess. 
In addition to the apparent Angle Class III malocclusion, there 
may be transverse and vertical issues that require attention.
Functional Class III problems
Functional Class III problems can be diagnosed by checking 
if there is a discrepancy between the maxilla and mandible 
in centric relation and centric occlusion.[7] In addition, 
patients should be evaluated in the vertical dimension for 
hypodivergent or hyperdivergent growth pattern. is 
diagnosis can be achieved by measuring the inclination of the 
occlusal plane (OP) and the ratio of lower anterior face height 
to total face height. It is notable that Class III functional shifts 
may also generate an asymmetry, which if left untreated can 
contribute to a true skeletal asymmetry.[8]
Early elimination of centric occlusion/centric rotation (CO/
CR) discrepancy will help in diagnosing the true underlying 
skeletal problems in all three planes of space and create a 
functional matrix that is more likely to lead to favorable and 
balanced growth of both jaws [Figure 2].[9]
Skeletal Class III problems
Patients with no functional or CO/CR discrepancy should 
also be evaluated in the vertical dimension to identify the 
Figure  1: Classification of developing Class  III malocclusion for 
early Treatment. CO: Centric occlusion; CR: Centric relation; 
LAFH: Lower anterior face height; OP: Occlusion plane inclination; 
TFH: Total facial height.
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growth pattern as hypodivergent or hyperdivergent. Several 
authors have recommended early treatment of Class  III 
skeletal problems to take advantage of growth modification. 
e validity of Phase II treatment is supported by studies that 
show greater orthopedic effects when treatment is started 
in younger patients.[10] Literature have shown that reasons 
do matter because decisions by orthodontists to treat early 
provide less invasive or nonsurgical treatment.[11]
With the advent of bone-anchored orthopedic device, 
Class III patients with maxillary deficiency may benefit more 
from early orthopedic treatment and more changes that 
are favorable for children and adolescents than previously 
thought.[12]
Orthopedic correction of mild and moderate skeletal 
Class  III conditions should be accompanied by regular 
progress evaluations to avoid creating significant dental 
compensations of the anterior dentition that can lead to 
adverse periodontal and esthetic outcomes with reduced 
long-term stability.
Poor candidates for growth modification are patients with 
mandibular excess and/or vertical excess. However, Class III 
malocclusions with mandibular excess seldom occur without 
some components of maxillary anteroposterior (AP) and 
vertical deficiency. erefore, if maxillary AP, transverse, 
and/or vertical deficiency are present, it still may be 
advantageous for the patient to have an early orthopedics to 
reduce the potential for these discrepancies to become worse. 
e remaining mandibular growth excess can then be treated 
as a one-stage/one-jaw procedure.
Longitudinal growth studies by Sugawara and Mitani showed 
similar maxillary and mandibular incremental growth 
change during pre-pubertal, pubertal, and post-pubertal 
periods when compared with Class I subjects.[13] e authors 
hypothesized that excess mandibular prognathism may be 
related to the change in OP or Wits appraisal.
Early orthodontic or orthopedic treatment to eliminate 
functional CO/CR discrepancy can be accomplished using 
expansion with a partial fixed appliance, orthodontic 
removable traction appliance, protraction face mask, removable 
functional appliance or chincap appliance therapy, or each of 
these at different stages or in combination.[14] Appliance choice 
should, therefore, take into consideration available patient/
parent “resources” for the required compliance.
It is important to set treatment objectives prior to initiation 
of early treatment to avoid prolonged Phase I treatment time. 
One of the key clinical objectives is to clearly communicate 
to the parents the goals of this stage of treatment (reference 
points) to achieve desired compliance and family support, 
thereby preserving needed resources for future stages of 
treatment.
Retention protocol is paramount after orthopedic or 
orthopedic Phase I treatment to maintain early anteroposterior, 
vertical, and transverse treatment results and maintain the 
achieved incisor alignment.[4] Frequently, bonded lingual 
arches are used to stabilize the aligned upper incisors which 
preserve smile esthetics and reduce the needed for long-term 
removable appliance wear, draining the patient’s “resources.”
Clinical decisions on Phase II Class III treatment
It is recommended that patients should wait until near 
completion of pubertal growth spurts prior to making 
decisions for Phase II treatment. In boys, it would be around 
17  years and 14  years of age in girls.[14,15] In many patients, 
the timing of initiation of Phase II will be determined by 
the skeletal age rather than the chronologic age. During this 
observation or waiting period, periodic monitoring and 
communication regarding initial treatment response and 
the long-term treatment objective are imperative to avoid 
starting Phase II treatment before all the growth data are 
assessed.
Clinicians will need to decide at that time whether the patient 
can be camouflaged with orthodontic tooth movement or 
wait until completion of growth for surgical treatment.
Musich developed a checklist [Figure  3] to help clinicians 
in planning whether to pursue nonsurgical treatment or 
surgical intervention. If the checklist review has several 
negative checkpoints, it will help the clinician to decide to 
proceed aggressively with a 4–8 months therapeutic diagnosis 
to confirm the nonsurgical or surgical decision or accept 
the fact that the best outcome can only be achieved with 
surgery.[4] e authors have found that the Class III checklist 
incorporates the 4 R’s of decision-making by the orthodontist 
and be a useful to guide the parent (and patient) to an optimal 
Figure  2: Treatment protocol for functional and skeletal Class  III 
patients.
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course of treatment reducing the chance a overtreatment or 
undertreatment. is checklist is also a good communication 
tool as to help the parents and the patient understands the 
reason for the decisions that are made.
e variables that enter into the analysis process make the 
orthodontist’s decision extremely difficult are factored into 
the Class III checklist:
•	 Is	there	a	family	history	of	mandibular	prognathism?
•	 Does	 the	 patient’s	 initial	 diagnosis	 include	mandibular	
prognathism or is the patient’s condition primarily 
due to maxillary retrusion? Note that the growth of 
the maxilla is primarily sutural and can be modified, 
whereas condylar growth is endochondral and is 
genetically controlled.
•	 After	following	the	patient	for	several	years,	what	is	the	
growth pattern, magnitude, and direction revealed by 




proceeds, indicative of a Class III pattern dominated by 
mandibular excess?
Assess treatment response using the Wits measure as a 
reliable guide:
•	 Wits	 changes	 will	 serve	 as	 a	 horizontally	 corrected	
growth treatment response vector.[16]
•	 Pre-treatment	Wits	 compared	 to	 the	 reevaluation	Wits	
(3–4  years after initiation of treatment) will give an 
indication of the stability of the initial correction, and 
this is useful to illustrate to patients and to parents the 
positive effect of the initial orthopedic therapy. Long-
term Class  III treatment requires ongoing positive 
reinforcement that progress is occurring.
Incorporate treatment response findings into recommendations 
of further treatment – nonsurgical or surgical depending 
on the severity of the Wits differential.[3]
•	 Does	the	superimposition	of	cephalograms	show	similar	
growth in amount and direction or differential growth of 
the maxilla and mandible?
•	 Is	 there	 additional	 growth	 that	 will	 undermine	 the	
current outcome?
•	 Is	the	response	to	Phase	I	treatment	favorable?	Does	the	
maxilla come forward with maxillary protraction? Does 
the mandible respond to chincap therapy with change in 
gonial angle?
•	 Is	 the	 patient	 complying	 with	 the	 mechanotherapy	 as	
needed? Are there ways to encourage great compliance 
if needed? Should new “non-compliance” strategy be 
introduced?
•	 If	 there	 is	 additional	 dental	 compensation	 available	
to achieve a stable/esthetic incisal relation and will 
the patient and the parents accept the facial esthetic 
outcome.
•	 What	 are	 the	 limits	 of	 dental	 compensation	 on	 an	
imbalanced Class  III skeletal relationship, functionally 
and esthetically and short-term and long-term?
•	 Will	growth	hormone	be	prescribed	by	 the	physicians?	
Clinicians need to be aware of the timing of hormone 
therapy and how it may impact the current maxilla-
mandibular growth imbalance.[17]
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